EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSNBRG00000021459
Gene Symbol: ADRA2C
4 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSNBRG00000004061
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSNBRG00000017928
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSNBRG00000001047
Gene Symbol: AKR1B1.1
1 Cross references
345 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSNBRG00000001013
Gene Symbol: LOC102797778
3 Cross references
343 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSNBRG00000018211
Gene Symbol: LOC102777698
3 Cross references
202 Possible Orthologues:

Alpha-1b Adrenergic Receptor-Like

Ensembl ID : ENSNBRG00000012174
Gene Symbol: LOC102784758
3 Cross references
191 Possible Orthologues:

Alpha-Galactosidase A-Like

Ensembl ID : ENSNBRG00000012000
Gene Symbol: LOC102782678
3 Cross references
196 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSNBRG00000008179
Gene Symbol: LOC102800155
2 Cross references
189 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSNBRG00000017266
Gene Symbol: LOC102789916
3 Cross references
231 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSNBRG00000013351
Gene Symbol: AMY1C
1 Cross references
213 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSNBRG00000006055
Gene Symbol: LOC102795649
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).